Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse

Cell

Volumn 83, Issue 3, 1995, Pages 473-482

  Morham, Scott G ^a   Langenbach, Robert ^b   Loftin, Charles D ^b   Tiano, Howard F ^b   Vouloumanos, Nectarios ^a   Jennette, J Charles ^a   Mahler, Joel F ^c   Kluckman, Kimberly D ^a   Ledford, Aric ^a   Lee, Christopher A ^b   Smithies, Oliver ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b National Institute   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ARTICLE; ENZYME INDUCTION; ENZYME SYNTHESIS; GENE DISRUPTION; KIDNEY DISEASE; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL;

ANIMALIA;

EID: 0028807498     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(95)90125-6     Document Type: Article

References (60)

1. Nephron adaptation to renal injury or ablation
2. Nonsteroidal anti-inflammatory drugs: differences and similarities
3. The association of nonsteroidal antiinflammatory drugs with upper gastrointestinal tract bleeding
4. Influence of age on compensatory renal growth in rats
5. Renal syndromes associated with nonsteroidal anti-inflammatory drugs
6. High level expression of active cyclooxygenase-2 in insect cells
7. Prostaglandin endoperoxide synthase: regulation of enzyme expression
8. PGH synthase isozyme selectivity the potential safer nonsteroidal antiinflammatory drugs
9. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
10. Prostaglandin G/H synthase isoenzyme 2 expression in fibroblasts: regulation by dexamethasone, mitogens and oncogenes
11. Structure of the mitogen-inducible TIS10 gene and demonstration that the T/S10-encoded protein is a functional prostaglandin G/H synthase
12. Drugswhich inhibit prostaglandin synthesis
13. Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of paracetamol (4-acetamidophenol)
14. Effects of anti-inflammatory drugs on prostaglandin biosynthesis
15. 2 synthase (cyclooxygenase) in human monocytes
16. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression and gene chromosomal assignment
17. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro
18. Development and validation of a alternative dermal sensitization test: the mouse ear swelling test (MEST)
19. Long-term effects of mild oligonephronia induced in utero by gentamicin in the rat
20. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increase with salt restriction
21. Hprt-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells
22. Characterization of a tyrosyl radical in prostaglandin endoperoxide synthase-2
23. Multiple sites on prostaglandin cyclooxygenase are determinants in the action of nonsteroidal anti inflammatory agents
24. Endothelin stimulates prostaglandin endoperoxide synthase-2 mRNA expression and protein synthesis through a tyrosine kinase-signalling pathway in rat mesangial cells
25. Recombinant fragment assay for gene targeting based on the polymerase chain reaction
26. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene
27. TIS10 a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells encodes a novel prostaglandin synthase/ cyclooxygenase homologue
28. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
29. Selective expression of a mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide
30. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes
31. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme
32. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic
33. The significance of focal segmental glomerularsclerosis in oligomeganephronia
34. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
35. Aspirin and myocardial infarction with an annotation on venous thrombosis
36. Interleukin 10 suppression of monocyte prostaglandin H synthase-2
37. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and 2
38. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase
39. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal antiinflammatory drugs and biosynthesis of 15-hydroeicosatetraenoic acid
40. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
41. Prostaglandin and leukotriene synthesis in mouse ears inflamed by arachidonic acid
42. Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase
43. Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages
44. Induction of cyclooxygenase-, in rat vascular smooth muscle cells in vitro and in vivo
45. TGF-pi inhibits both endotoxin-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene in murine macrophages
46. Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by antiinflammatory drugs
47. Aspirin as a quantitative acetylating reagent for the fatty acid oxygenase that forms prostaglandins
48. Isolation and covalent structure of the aspirin modified, active-site region of prostaglandin synthase
49. Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/ cyclooxygenase activity
50. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis
51. Essential histidines of prostaglandin endoperoxide synthase
52. Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis
53. Multiple cyclooxygenases: cloning of a mitogen inducible form
54. Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1)
55. Interactions of PGH synthase isozymes-1 and -2 with NSAIDs
56. Signal transduction pathways responsible for serotonin-mediated prostaglandin G/H synthase expression in rat mesangial cells
57. Aspirin use and reduced risk of fatal colon cancer
58. Aspirin use and the risk of fatal cancer
59. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
60. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure: a prospective, randomized, crossover comparison